PL3452019T3 - Zastosowanie alkoholi cukrowych w kompozycjach tybolonu - Google Patents
Zastosowanie alkoholi cukrowych w kompozycjach tybolonuInfo
- Publication number
- PL3452019T3 PL3452019T3 PL17723960T PL17723960T PL3452019T3 PL 3452019 T3 PL3452019 T3 PL 3452019T3 PL 17723960 T PL17723960 T PL 17723960T PL 17723960 T PL17723960 T PL 17723960T PL 3452019 T3 PL3452019 T3 PL 3452019T3
- Authority
- PL
- Poland
- Prior art keywords
- sugar
- alcohols
- tibolone
- compositions
- tibolone compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 150000005846 sugar alcohols Chemical class 0.000 title 1
- WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 title 1
- 229960001023 tibolone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16168390 | 2016-05-04 | ||
| EP17723960.5A EP3452019B1 (en) | 2016-05-04 | 2017-05-04 | Use of sugar-alcohols in tibolone compositions |
| PCT/EP2017/060676 WO2017191266A1 (en) | 2016-05-04 | 2017-05-04 | Use of sugar-alcohols in tibolone compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3452019T3 true PL3452019T3 (pl) | 2021-12-20 |
Family
ID=55919671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17723960T PL3452019T3 (pl) | 2016-05-04 | 2017-05-04 | Zastosowanie alkoholi cukrowych w kompozycjach tybolonu |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10736907B2 (pl) |
| EP (1) | EP3452019B1 (pl) |
| AU (1) | AU2017260799B2 (pl) |
| BR (1) | BR112018072371B1 (pl) |
| CY (1) | CY1124392T1 (pl) |
| DK (1) | DK3452019T3 (pl) |
| ES (1) | ES2889598T3 (pl) |
| HU (1) | HUE055164T2 (pl) |
| MX (1) | MX381207B (pl) |
| PL (1) | PL3452019T3 (pl) |
| PT (1) | PT3452019T (pl) |
| SM (1) | SMT202100536T1 (pl) |
| WO (1) | WO2017191266A1 (pl) |
| ZA (1) | ZA201807210B (pl) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE665514A (pl) | 1964-06-16 | |||
| US4701450A (en) * | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
| IE63051B1 (en) | 1989-03-18 | 1995-03-22 | Akzo Nv | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one |
| IL123984A (en) | 1997-04-22 | 2004-09-27 | Akzo Nobel Nv | Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable |
| WO2003032924A2 (en) | 2001-10-18 | 2003-04-24 | Ivax Corporation | Novel tibolone formulations |
| TW200418525A (en) | 2002-11-20 | 2004-10-01 | Akzo Nobel Nv | Coated pharmaceutical tablets containing Tibolone |
| ES2274386T3 (es) | 2004-02-06 | 2007-05-16 | Helm Ag | Preparaciones farmaceuticas que contienen tibolona amorfa. |
| WO2005117899A1 (en) | 2004-06-02 | 2005-12-15 | Cipla Limited | Pharmaceutical composition comprising tibolone and process for procuding the same |
| CZ300465B6 (cs) | 2007-07-25 | 2009-05-27 | Zentiva, A. S. | Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu |
| CN102085193B (zh) * | 2009-12-08 | 2013-11-06 | 北京以岭生物工程技术有限公司 | 一种替勃龙口腔崩解片及其制备方法 |
| JP6775155B2 (ja) | 2015-09-14 | 2020-10-28 | 日本新薬株式会社 | 錠剤 |
-
2017
- 2017-05-04 MX MX2018013274A patent/MX381207B/es unknown
- 2017-05-04 DK DK17723960.5T patent/DK3452019T3/da active
- 2017-05-04 HU HUE17723960A patent/HUE055164T2/hu unknown
- 2017-05-04 SM SM20210536T patent/SMT202100536T1/it unknown
- 2017-05-04 WO PCT/EP2017/060676 patent/WO2017191266A1/en not_active Ceased
- 2017-05-04 EP EP17723960.5A patent/EP3452019B1/en active Active
- 2017-05-04 PL PL17723960T patent/PL3452019T3/pl unknown
- 2017-05-04 BR BR112018072371-1A patent/BR112018072371B1/pt not_active IP Right Cessation
- 2017-05-04 AU AU2017260799A patent/AU2017260799B2/en not_active Ceased
- 2017-05-04 US US16/095,917 patent/US10736907B2/en active Active
- 2017-05-04 PT PT177239605T patent/PT3452019T/pt unknown
- 2017-05-04 ES ES17723960T patent/ES2889598T3/es active Active
-
2018
- 2018-10-29 ZA ZA2018/07210A patent/ZA201807210B/en unknown
-
2021
- 2021-08-03 CY CY20211100694T patent/CY1124392T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT3452019T (pt) | 2021-07-28 |
| MX381207B (es) | 2025-03-12 |
| AU2017260799A1 (en) | 2018-12-13 |
| ZA201807210B (en) | 2022-04-28 |
| MX2018013274A (es) | 2019-03-06 |
| WO2017191266A1 (en) | 2017-11-09 |
| US20190134058A1 (en) | 2019-05-09 |
| EP3452019A1 (en) | 2019-03-13 |
| AU2017260799B2 (en) | 2022-11-24 |
| CY1124392T1 (el) | 2022-07-22 |
| BR112018072371B1 (pt) | 2024-04-30 |
| US10736907B2 (en) | 2020-08-11 |
| DK3452019T3 (da) | 2021-09-06 |
| BR112018072371A2 (pt) | 2019-02-19 |
| SMT202100536T1 (it) | 2021-11-12 |
| HUE055164T2 (hu) | 2021-11-29 |
| ES2889598T3 (es) | 2022-01-12 |
| EP3452019B1 (en) | 2021-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2564307B (en) | Foam compositions and uses thereof | |
| IL256621A (en) | Carrier-binder preparations and methods for their preparation and use | |
| ZA201701244B (en) | Carrier-antibody compositions and methods of making and using the same | |
| IL250568A0 (en) | Anti-methanogenic preparations and their uses | |
| SG11201607600TA (en) | Vaginal composition and use thereof | |
| GB201608762D0 (en) | Compositions and uses thereof | |
| GB201411196D0 (en) | Composition and use thereof | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| GB201501991D0 (en) | Uses and compositions | |
| GB201502026D0 (en) | Uses and compositions | |
| IL261794A (en) | Preparations and methods for using them | |
| GB201614897D0 (en) | Compositions and uses thereof | |
| GB201511886D0 (en) | Uses and compositions | |
| ZA201807210B (en) | Use of sugar-alcohols in tibolone compositions | |
| GB201911959D0 (en) | Immunogenic compositions and uses therefor | |
| IL247645A0 (en) | Preparations of seleno-organic compounds and methods of using them | |
| GB201602409D0 (en) | Compositions and uses thereof | |
| GB201522814D0 (en) | Compositions and uses thereof | |
| ZA201805806B (en) | Fragranced compositions and their use | |
| GB201621959D0 (en) | Compositions and their use | |
| GB201602665D0 (en) | Compositions and their use | |
| IL252660A0 (en) | Compounds characterized by an inverse freezing property and their uses | |
| GB201602404D0 (en) | Compositions and uses thereof | |
| GB201602406D0 (en) | Compositions and uses thereof | |
| GB201602398D0 (en) | Compositions and uses thereof |